Nuvo Pharmaceuticals (TSE: NRI- OTCQX: NRIFF) President and CEO Jesse Ledger joined Steve Darling from Proactive in Vancouver to discuss the company’s Nuvo Ireland announcing Takeda Pharmaceutical has given notice Japan's Ministry of Health, Labor and Welfare have approved Cabpirin combination tablets.
Ledger discusses what this means for the company and its revenue going forward. Ledger also told Proactive how the company is dealing with COVID-19 right now and in the future.